Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Randomized Double Blind Placebo-Controlled Study to Determine the Efficacy of ABR-215050 in Asymptomatic Patients With Metastatic Castrate-Resistant Prostate Cancer

NCT00560482 is registered in ClinicalTrials.gov with Active Biotech AB as lead sponsor.

NCT NCT00560482
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00560482 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Randomized Double Blind Placebo-Controlled Study to Determine the Efficacy of ABR-215050 in Asymptomatic Patients With Metastatic Castrate-Resistant Prostate Cancer
Lead sponsor
Active Biotech AB
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2007
Completion date
August 31, 2015
Enrollment
206 (actual)
Sites
65

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer